The Pharmalot View
Most Read
Azar has a ‘tin ear’ when it comes to pricing a potential coronavirus treatment
The military pushed it for the battlefield. The FDA went along. Is the newest opioid any better?
Kapoor certainly deserves to go to jail, but so do some other pharma execs
We shouldn’t rush to use an unproven malaria drug to treat the coronavirus
Where’s the data? In a pandemic, now is no time to sit on Covid-19 trial results
Dear Scott Gottlieb: Add new warnings to Paxil labels. You may save a life
